Recombinant Vaccines Market Information: By Product (Subunit Recombinant and Attenuated Recombinant Vaccines), by Disease (Cancer, Pneumococcal Disease, Hepatitis B, and DPT), and End-Users (Pediatrics, Adults, and Veterinary) – Global Forecast Till 2027 Key Players: Some of the key players in the Recombinant Vaccines Market Analysis are Abiomed, Emergent Bio Solutions, Inc.,...

Kings Research™ presents this information in its report titled, “Vaccine Market Size, Share & Industry Analysis, By Technology (Live Attenuated Vaccines, Conjugate Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Vaccines), Disease Indication (Pneumococcal Disease, Influenza, Human Papillomavirus, Meningococcal Disease, Rotavirus, Varicella,...

Increasing government funding for vaccine production and growing emphasis on immunization are major factors expected to drive the market Vaccines Market Size – USD 42 Billion in 2020, Market Growth – 7.3% Market Trends – Expanding pharmaceutical industry and drive to vaccinate all The global Vaccines Market size is expected to reach USD 73.78 billion by 2028,...